The stereotypical pattern of neurofibrillary tangle spreading in the earliest stages of typical Alzheimer's dementia (AD) predicts that medial perirhinal cortex (mPRC) atrophy precedes entorhinal cortex (ERC) atrophy, whereas the status of the parahippocampal cortex (PHC) remains unclear. Atrophy studies have focused on more advanced rather than early AD patients, and usually segment the entire PRC as opposed to the mPRC versus lateral PRC (lPRC). The present study therefore determined the extent of ERC, mPRC, lPRC, and PHC atrophy in very early AD (mean Mini-Mental State Examination score ¼ 26) patients and its presumed prodrome amnestic mild cognitive impairment (mean Mini-Mental State Examination score ¼ 28) compared to demographically matched controls. PHG structures were manually segmented (blinded rater) and cortical thicknesses extracted. ERC and mPRC were similarly atrophied in both patient groups. The lPRC was atrophied in the AD group only. Thus, atrophic changes in very early AD broadly map onto the pattern of neurofibrillary tangle spreading and suggest that mPRC, ERC, and lPRC, but not PHC-associated functional impairments, characterize very early-stage AD.
Introduction
The early stages of Alzheimer's dementia (AD) are associated with atrophy of the parahippocampal gyrus (PHG, i.e., entorhinal cortex [ERC] , perirhinal cortex [PRC] and parahippocampal cortex [PHC] ) of the medial temporal lobe (MTL). In typical AD, neurofibrillary tau pathology begins in the transentorhinal cortex (i.e., medial PRC [mPRC] ), from where it spreads to the ERC (transentorhinal stages) and to the hippocampal subfields (limbic stages) before spreading into the lateral PRC (lPRC) and isocortical structures (Braak and Braak, 1991; Braak and Del Tredici, 2006; Kordower et al., 2001; Taylor and Probst, 2008) . Most investigations of atrophy in AD or its putative prodrome amnestic mild cognitive impairment (aMCI) focus on ERC and hippocampal atrophy, but rarely on that of the PRC, in particular its medial versus lateral aspects (e.g., Du et al., 2001) . Also, it is unclear to what extent the PHC is affected in the earliest stages of AD. Finally, it remains unclear whether the brunt of PHG thinning is concentrated in specific anterior-to-posterior levels and, thus, which corresponding coronal levels are optimally clinically informative for distinguishing between healthy normal controls (NCs) and very early AD patients. The present study addresses these questions by manually segmenting the key PHG structures on high-resolution magnetic resonance imaging (MRI) scans according to a cytoarchitectonic-, chemoarchitectonic-, and connectivity-based protocol Kivisaari et al., 2013b; Taylor and Probst, 2008) in a large group of healthy control subjects and very early AD patients.
The progressive accumulation of neurofibrillary tangles (NFTs) is assumed to be causally related to cortical atrophy in AD (Ball, 1978; Gómez-Isla et al., 1997) . Pyramidal cells in the mPRC are the first cortical neurons to be affected by NFTs (stage I; Braak, 1991, 1995; Kordower et al., 2001) . We note that the mPRC corresponds to Braak and Braak (1991) "transentorhinal cortex" (Taylor and Probst, 2008) . Next, cells in layer II of the ERC are affected before pathology spreads to the hippocampal formation (stage II) and into layer IV of the ERC (stage III) (Braak and Del Tredici, 2006) . The lPRC is affected in stage III (Braak and Braak, 1991; Braak and Del Tredici, 2006; Van Hoesen et al., 2000) . If atrophy mainly results from tau pathology, this progression of pathology predicts that cortical thinning of the mPRC precedes that of the lateral ERC. However, this pattern may not be apparent on structural MRI, since the involvement of a single cortical layer (e.g., mPRC stages I, II) may not cause sufficient cortical thinning for its detection on structural MRI scans. That is, ERC atrophy may be visible on MRI before mPRC atrophy, because 2 independent cortical layers of the ERC (i.e., layers II and IV) are affected early in the disease process compared to a single mPRC layer. Moreover, it is unclear whether the PHC is affected by the pathological tau accumulation in the earliest stages of AD. This is a critical point, since early PHC atrophy could explain some of the cognitive (e.g., visuospatial: Epstein and Kanwisher, 1998) impairments associated with early AD.
MRI-based studies of regional PHG integrity in mild-tomoderate AD patients consistently report atrophy of these structures. Juottonen et al. (1998) Folstein et al., 1975 ] range 14e28) with 32 NC participants. They found that each region was significantly atrophied in AD patients, with the ERC significantly more severely affected than the entire PRC. Similarly, Teipel et al. (2006) reported comparable extents of atrophy when analyzing the volumes of the entire PRC, PHC, and ERC of AD patients (n ¼ 34; MMSE scores !10) to NCs (n ¼ 22). Measures of cortical thickness may provide a more accurate measure of atrophy than 3-dimensional volumes, especially in anatomically highly variable regions such as the PRC, where volumetric measurements are confounded by the size of this structure which varies widely between individuals according to the depth and number of collateral sulci (CS; Insausti et al., 1998) . Using mean cortical thickness measurements, Lerch et al. (2005) demonstrated severe cortical thinning of the entire PHG in 19 AD patients (MMSE range, 10e29) compared to 17 NCs, with a significant group difference in the anterior portion of the left ERC, which was the only cytoarchitectonic field that was individually segmented. Dickerson et al. (2009) segmented each PHG subfield in 29 AD patients (MMSE range, 16e28) and found significant cortical thinning of the ERC, mPRC (estimated by the medial bank of the collateral sulcus), and PHC compared to 47 NC participants. Taken together, these studies demonstrate significant and comparable extents of atrophy in the ERC, PRC, and PHC in the mild-tomoderate stages of AD.
The comparable degree of PHG atrophy reported in the aforementioned studies does not at first blush map onto the progression of NFT pathology as described by Braak and Braak (1995) . However, the AD patients investigated were either in mild-to-moderate stages of the disease, or the samples were highly variable with respect to disease stage (MMSE scores range from 10 to 29). Thus, neurofibrillary pathology was presumably more dense and widespread compared to patients in the early stages of the disease. Therefore, very early AD patients who are expected to be in early stages of NFT pathology should be examined (Geddes et al., 1997; Nelson et al., 2012) . Second, it is essential to segment the mPRC from the lPRC, as cortical NFT begins in the mPRC (stage I), whereas the lPRC is only affected by NFT in stage IV. The anatomic borders of the mPRC corresponding to Braak and Braak's "transentorhinal region" were described by Taylor and Probst (2008) and subsequently integrated into an MTL segmentation protocol (Kivisaari et al., 2013b) incorporating aspects of the Insausti et al. (1998) criteria. Given the high anatomic variability of the CS, which defines mPRC and lPRC boundaries, it is necessary to segment these structures manually to achieve anatomic precision (Hanke, 1997; Pruessner et al., 2002) .
The purpose of the present study was to adopt the approach described previously to determine the location and extent of cortical thinning in the ERC, mPRC, lPRC, and PHC in 2 groups of patients with very early AD, that is, a group of aMCI patients presumed to be in the prodromal phases of AD (Petersen et al., 2006) , and a group of mildly affected AD patients. All regions of interest (ROIs) were manually segmented by an investigator blinded to diagnosis (Sabine Krumm) using an anatomical protocol recapitulated here (Kivisaari et al., 2013b) . Specifically, we aimed to determine whether, in the very early stages of AD, (1) the mPRC and/or ERC is significantly atrophied (1 vs. 2 layers) and (2) PHC thinning is apparent. The first question tests the hypothesis that cortical thinning maps onto the pattern of neurofibrillary pathology, and the second question addresses the unknown status of the PHC in the earliest stages of AD. Both issues are highly clinically relevant as they advise clinicians of the anatomic structures to focus on during the diagnostic process and indicate which corresponding cognitive impairments are expected in the early stages of AD (see e.g., Kivisaari et al., 2012) . Finally, we asked whether (3) cortical thinning is maximized in specific anterior-toposterior coronal levels which would reflect the optimal slices on which to clinically detect very early AD.
Methods

Participants
Data from 121 native Swiss-German or German-speaking adults were included in the present study: 64 healthy control participants (NC) and 57 individuals with very early AD (see the following paragraph). The healthy control participants had undergone a thorough medical screening and neuropsychological testing to ensure that they were cognitively (i.e., neurologically and psychiatrically) healthy. Specifically, exclusion criteria included severe auditory, visual or speech deficits; severe sensory or motor deficits; severe systemic disease; continuous mild-to-intense pain; diseases with severe or probable impact on the central nervous system (e.g., neurologic disorders including cerebral-vascular disease, generalized atherosclerosis, and psychiatric problems); and intake of potent psychoactive substances except mild tranquilizers. In addition, all NCs received normal scores on the MMSE (Folstein et al., 1975) , California Verbal Learning Task (Delis et al., 1987) , Clock Drawing Test (Critchley, 1953) , and short version of the Boston Naming Test (Kaplan et al., 1983) .
Thirty-four participants (16 male, 18 female) were diagnosed with AD according to NINCDS-ADRDA and DSM-IV criteria (American Psychichiatric Association, 1994) and 23 patients (11 male, 12 female) with mild neurocognitive disorder because of AD according to DSM-IV and Winblad et al. (2004) criteria ( aMCI; single-, or multi-domain). All patients had been recruited from the Memory Clinic, University Center for Medicine of Aging in Basel, Switzerland, where they had received neuropsychological testing, MRI scanning, and medical and neurological examinations including blood analyses. As many NC participants as possible were demographically matched to the aMCI group and AD patients with regard to age, gender, and education (all p-values > 0.3; see Table 1 ). As expected, mean MMSE scores of the aMCI and the AD groups significantly differed from their respective control groups (NC vs. aMCI: F(1,67) ¼ 8.55, p < 0.01; NC vs. AD: F(1,63) ¼ 47.19, p < 0.001). Critically, the mean MMSE scores of both patients groups indicate that they were mildly affected.
MRI measures 2.2.1. MRI acquisition
All participants received MRI scanning conducted on a 3-T head scanner (MAGNETOM Verio, Siemens) at the University Hospital Basel (T1-weighted 3D magnetization-prepared rapid acquisition gradient echo; inversion time ¼ 1000 ms; repetition time ¼ 2000 ms; echo time ¼ 3.75 ms; flip angle ¼ 8 ; field of view ¼ 256 Â 256; acquisition matrix ¼ 256 Â 256 mm; voxel size ¼ 1 mm isotropic).
Preprocessing of structural MR images
Preprocessing of MRI scans was conducted using FreeSurfer (Massachusetts General Hospital, Boston, MA; http://surfer.nmr. mgh.harvard.edu; Dale et al., 1999; Fischl and Dale, 2000) . Magnetization-prepared rapid acquisition gradient echo volumes were semiautomatically segmented into gray and white matter and the pial and gray/white matter surfaces were formed (Dale et al., 1999) . Tissue next to the anteromedial temporal lobe was removed by hand because it interfered with the cortical surface reconstructions. The cortical thickness is defined as the distance between corresponding vertices on the gray/white matter and pial surfaces. The total intracranial volume (TIV; gray matter þ white matter þ CSF volumes) per participant was estimated using SPM8 (Wellcome Institute of Cognitive Neurology) implemented in Matlab 2010 (Mathworks Inc., Sherborn, MA, USA).
Regions of interest
To our knowledge, no available software accurately and automatically segments the mPRC and lPRC on MRI images. However, the creation of labels for these regions is necessary to extract cortical thickness data. MTL ROIs were therefore manually drawn by a blinded rater (Sabine Krumm) on coronal slices of the native space cortical surface reconstructions generated by FreeSurfer according to anatomic landmarks described in Kivisaari et al. (2013b) which was based primarily on Insausti et al. (1998) . We note that the major deviation between the Insausti et al. (1998) and Kivisaari et al. (2013b) protocols is the latter's inclusion of landmarks to segment the mPRC and lPRC based on Taylor and Probst (2008) . Left and right hemispheric ROIs were drawn for the mPRC, lPRC, ERC, and PHC. The mPRC corresponds to the transentorhinal region, considered as an area of transition between ERC and PRC (Braak and Braak, 1985; Taylor and Probst, 2008) . For the purposes of the present study, only portions of the PRC lateral to the ERC were segmented, that is, the most anterior and posterior aspects of the PRC, which wrap medially around the most anterior and posterior part of the ERC, were not segmented because to our knowledge no cytoarchitectonic data exist to delineate the PRC subregions here (Taylor and Probst, 2008) . The detailed manual segmentation protocol is described in Im et al., 2008) . However, we note that PRC cortical thickness values are less susceptible to variations in CS depth compared to "volumetric" measures (see the previously mentioned paragraphs).
Cortical thickness estimates
Three-dimensional measurements of atrophy in PHG regions and especially the PRC, such as volumetric measures, depend on the number and depth of the CS (i.e., deeper CS are associated with more voluminous PRCs). To compare atrophy across ROIs while controlling for intraindividual differences in the size of the PRCs, we used a measure that is independent of volume (i.e., the depth of the collateral sulcus), namely the cortical thickness of each manually segmented ROI. Mean cortical thickness values for each ROI were obtained using FreeSurfer (Massachusetts General Hospital, Boston, MA; http://surfer.nmr.mgh.harvard.edu; Dale et al., 1999; Fischl and Dale, 2000) , and individual cortical thickness values for each vertex were extracted using Matlab 2010 (Mathworks Inc., Sherborn, MA; USA). By default, FreeSurfer sets the cortical thickness maximum to 5 mm because a former study demonstrated that this upper limit included the large majority of cortical thickness estimates (Fischl and Dale, 2000) . However, 2.4% of our thickness values exceeded the 5 mm maximum, resulting in a non-normal distribution. Therefore, we changed this limit to 10 mm and visually inspected the location of each vertex exceeding 5 mm. Two of 9384 vertices were not lying within our ROIs and were therefore excluded; the remaining vertices were included in the subsequent analyses. The right-anterior-superior coordinates were converted into Montral Neurological Institute (MNI) coordinates in FreeSurfer. Mean patient cortical thickness values were transformed into standard (z-) scores for graphic visualization according to the following formulae: ([mean patient cortical thickness value]À[corresponding mean NC cortical thickness])/(corresponding NC standard deviation of mean cortical thickness). Three-dimensional graphical depictions of these vertex-wise mean cortical thickness z-scores representing NC and patient differences in cortical thickness over the cortical surface were plotted in Matlab 2010.
Statistical analyses
Cortical thickness estimates used in the statistical analyses were normalized for head size (TIV; [(cortical thickness)/(TIV)] Â 100) and retransformed into metric values (mm) for tabular reporting to facilitate interpretation. To determine which demographic variables and whether hemisphere should be included as covariates in the statistical analyses of group differences, we performed a (Scahill et al., 2002; Seo et al., 2011; Skullerud, 1984) , all 3 demographic variables were included as covariates in all analyses of group differences, and cortical thickness estimates in each ROI were collapsed over the hemispheres. Post hoc 2-sided t tests were corrected according to the Hochberg GT2 procedure for unequal sample sizes. Significance levels were corrected for multiple comparisons according to Bonferroni. All statistical analyses were performed using SPSS 21.0 (IBM Corp Released 2012. IBM SPSS Statistics for Windows, version 21.0, Armonk, NY, USA).
Results
Regional parahippocampal gyrus thinning in aMCI and AD patients
Two-tailed, univariate ANCOVAs with sex, age, and education as covariates were performed to determine whether each PHG ROI was atrophied in the aMCI and AD groups relative to their corresponding NC sample. Table 3 .
Estimated progression of cortical thinning in very early AD
To estimate the progression of regional PHG thinning from aMCI to AD stages, patients' cortical thickness values were transformed into standard (z-) scores based on the mean and standard deviation of their respective demographically matched control group and compared with 2-tailed, unpaired t tests. These analyses revealed that ERC and mPRC significantly differed between aMCI and AD patients, while lPRC and PHC did not [ERC: t (55) This protocol segments the transentorhinal area of the PRC lateral to the ERC; therefore, the most anterior and posterior portions of the PRC wrapping around the ERC (e.g., 3e4 mm posterior to the last slice still containing the apex of the intralimbic gyrus) were not included in the mPRC and lPRC ROIs. Key: CS, collateral sulcus; ERC, entorhinal cortex; lPRC, lateral perirhinal cortex; mPRC, medial perirhinal cortex; MRI, magnetic resonance imaging; PHC, parahippocampal cortex; ROI, region of interest.
Coronal levels displaying maximal ERC and mPRC thinning in aMCI and AD patients
In the clinical setting, coronal slices of anatomic MRI scans are examined for PHG thinning indicative of AD. The next analysis aimed to determine whether ERC and mPRC thinning was disproportionately manifested in specific coronal (MNI y-coordinate) levels. To address this question, we compared normalized cortical thickness values at each vertex coordinate of the NC versus AD group. This analysis was conducted on y-levels containing minimally 90%e95% of the distribution of data points, corresponding to the mid anterior-to-posterior section (MNI y-levels between À22 and À3), to minimize spurious findings.
Two univariate ANOVAs, one for the mPRC and one for the ERC, with mean normalized cortical thickness values at each y-level as the dependent variable, and diagnosis, hemisphere and MNI y-coordinate as independent variables, were conducted to determine whether cortical thinning (i.e., a difference between control and patient thickness) was exacerbated at specific y-levels (i.e., a significant interaction between group and y-level). This was indeed the case for both the ERC and mPRC: we found a 3-way interaction between group, y-level, and hemisphere [ERC: F(19, 31,765) ¼ 3.241, p < 0.001; mPRC: F(19, 30,533) ¼ 2.703, p < 0.001]. Additional post hoc tests identified the nature of these interactions, that is, that maximal cortical thinning in the ERC and mPRC was constrained to different y-levels in each hemisphere. Specifically, left hemisphere ERC cortical thinning was maximal at y-levels À3 to À5, and in levels À5 to À7 in the right hemisphere (Bonferroni-corrected univariate ANCOVAs of NC vs. AD and left hemisphere y-levels (MNI y-levels between À22 and À3): F(19, 16,221) ¼ 14.866, p < 0.0125; same ANCOVA with right hemisphere y-levels: F(19, 165541) ¼ 9.705, p < 0.0125). Maximal cortical thickness in the mPRC was also evident at different anterior-to-posterior extents. In the left Fig. 1 . Z-transformed mean thickness values for aMCI and AD participants for each ROI. Standard error bars are displayed (AE1 SE). *Significant differences at p < 0.05. Abbreviations: AD, Alzheimer's dementia; aMCI, amnestic mild cognitive impairment; ERC, entorhinal cortex; lPRC, lateral perirhinal cortex; mPRC, medial perirhinal cortex; PHC, parahippocampal cortex; ROI, region of interest; SE, standard error. Bolded text represents vertices of maximal differences in cortical thickness between AD patients and healthy controls. Key: AD, Alzheimer's dementia; ERC, entorhinal cortex; ES, effect size; mPRC, medial perirhinal cortex; NC, normal controls; ROI, region of interest; SD, standard deviation. Table 3 Normalized and retransformed mean cortical thicknesses in each ROI over both hemispheres hemisphere, maximal differences in mPRC cortical thickness was found at y ¼ À8, whereas maximal differences in the right hemisphere mPRC was specific to y-levels À7 and À8 [Bonferronicorrected univariate ANCOVAs of NC vs. AD and left hemisphere y-levels (MNI y-levels between À22 and À3): F(19, 15,769) ¼ 2.590, p < 0.0125; same ANCOVA with right hemisphere y-levels: F(19, 14,761) ¼ 4.195, p < 0.0125]. Table 4 summarizes these results by indicating the MNI y-coordinates where NCs maximally differed from AD patients (i.e., where p < 0.05 and effect size !0.3). To illustrate the general patterns of atrophy, the distribution of cortical thickness differences between NCs and AD patients in the ERC and mPRC are plotted in Fig. 2 . We note that although the maximal difference in NC versus AD ERC cortical thickness was found in the right hemisphere (cf. red portion of ERC difference, Fig. 2 ), the nature of the variance at each y-level generated the largest statistical difference in the left hemisphere ERC.
Discussion
Patients with aMCI evidence cortical thinning of the mPRC as well as the ERC but neither the lPRC nor the PHC. However, the lPRC was also significantly atrophied in AD patients. The cortical thickness of the PHC remained intact in the aMCI and AD patients. With increasing clinical progression at this early stage (aMCI vs. early AD), more impaired patients similarly showed significantly thinner mPRC's and ERC's. However, there were no significant differences with respect to the lPRC or PHC when comparing aMCI versus AD patients. These findings based on rigorous anatomic segmentation add new aspects to the literature on atrophy in AD by showing that when patients in the earliest stages of AD are investigated, differential thinning can indeed be documented within ROIs of the PHG, in contrast to negative results from previous reports (e.g., Dickerson et al., 2009; Teipel et al., 2006) . The present findings are relevant to understanding the relationship between the hierarchical order of cortical progression of NFT pathology and regional cortical thinning, as well as the associated cognitive impairments predicted in the earliest stages of the disease. Finally, the present findings generate recommendations for the reliable and practical clinical identification of early AD-associated thinning on structural MRI scans.
The staging of NFT-related pathology predicts that NFTs occur first in the mPRC followed by the ERC, and much later in the lPRC (Braak and Braak, 1995) . This stereotypical pattern of NFT progression is presumed to be accompanied with thinning in the respective regions, although the precise mechanism relating NFT pathology with cortical atrophy (and neuronal functioning) remains to be determined. The present findings are broadly consistent with this hypothesis: both mPRC and ERC demonstrated thinning in both patient groups, whereas lPRC thickness was atrophied in the AD group only, a pattern which is generally consistent with the spread of cortical neurofibrillary pathology as described by Braak (1991, 1995) . However, we found no evidence that the mPRC was atrophied to a greater extent than the ERC, as hypothesized from the anatomic progression of NFT. Similar negative findings were reported by other research groups (Dickerson et al., 2001; Galton et al., 2001; Jack et al., 1997; Kordower et al., 2001; Scahill et al., 2002; Xu et al., 2000) , although these studies did not segment the mPRC from the lPRC and investigated patients in more advanced or variable stages of the disease. It seems that the ERC and mPRC may show comparable relative thinning in the early stages of AD. Because the ERC is thicker than the mPRC (e.g., Dickerson et al., 2009) , the ERC would show greater absolute change in thickness than the mPRC (e.g., a 10% reduction in a 4-mm cortical thickness is a greater absolute change than a 10% reduction in a 3 mm cortical thickness). However, thinning relative to region size is expected to be comparable in both ROIs or greater in mPRC than ERC in the earliest stages of the atrophy since the former structure is affected first (Braak et al., 1991 (Braak et al., , 1995 . Indeed, we found comparable or slightly greater relative decreases in patients' mPRC (9% and 22% for aMCI and AD patients, respectively) than their ERC (8% and 18% for aMCI and AD patients, respectively). We note that the estimates of relative ERC thinning are comparable to those reported by Velayudhan et al. (2013) using the automatic ERC segmentation tool provided by FreeSurfer (NC vs. MCI: 7%; NC vs. AD: 19%; present study: NC vs. aMCI: 8%; NC vs. AD: 18%). The availability of MRI processing software, which automatically and reliably segments the ERC (Desikan et al., 2006; Fischl et al., 2002; Shaker and Soltanian-Zadeh, 2008; Yushkevich et al., 2015) and recently the mPRC (Augustinack et al., 2013) , noticeably economizes the segmentation process compared to manual segmentation. However, the validity of the automatic mPRC segmentation remains to be established, especially for complex (e.g., bifurcated) CS, although very recent effort in this direction has been made (e.g., Yushkevich et al., 2015) .
Critically, the present study found no significant PHC thinning in the aMCI and AD groups. This finding contrasts with those reported by Teipel et al. (2006) and Dickerson et al. (2009) , both of whom reported significant PHC atrophy in their AD patients. However, the patients investigated in these studies were in more advanced disease stages (mean MMSE score, 23.1 [lowest score, 10], respectively, MMSE range, 16e28) compared to the present samples (MMSE range 22e30). Correspondingly, Thangavel et al. (2008) report substantial NFT load in layers III and V of areas TF (area fusiformis) and TH (area temporohippocampica; corresponding with the PHC) in postmortem brains of AD patients in presumably severe stages of their disease (9e12 years disease duration). Thus, taken together, the results of these and the present studies indicate that atrophy of the mPRC and ERC occurs before atrophy of the PHC. Clearly, individuals in prodromal stages of the disease who are later definitively diagnosed with Alzheimer's disease must be longitudinally studied to determine the first cortical site of atrophy and the longitudinal progression of atrophy in the PHG substructures.
Detailed vertex-vice investigations of cortical thickness values revealed the coronal slices with maximal ERC and mPRC cortical thinning in AD versus control participants, namely anterior slices ranging from MNI y ¼ À3 to À8, that is, the region between 4 and 9 mm posterior to the most anterior slice where the amygdala is first visible. Although for ERC the most discriminative slices were situated in the left hemisphere only, they were situated in both hemispheres for mPRC. These findings can be applied in the clinical setting to reliably detect ERC and mPRC thinning in potential very early AD patients. To our knowledge, this is the first study that provides specific y-MNI coordinates that aim to support the process of AD diagnosis in the clinical as well as the research setting.
The cognitive domains that appear to be affected in the earliest stages of aMCI and AD using standard clinical neuropsychological tests are verbal and visual episodic memory (Salmon, 2011) . Indeed, a recent study by Mistridis et al. (2015) demonstrates that verbal memory performance declined already 8 years before the diagnosis of MCI preceding AD (n ¼ 27) compared to 60 participants who remained cognitively healthy. These neurocognitive functions are strongly associated with the hippocampus and the ERC (Lipton and Eichenbaum, 2008) . The PRC, which is affected by NFT before the ERC, has been associated with the processing of semantic object memories and object recognition memory (Kivisaari et al., 2013b) . Although some studies report that these functions, when measured by the semantic fluency test, decline first or concurrently with episodic memory (Amieva et al., 2005 (Amieva et al., , 2008 , most studies report that decline in episodic memory precedes semantic memory impairment (Grober et al., 2008; Saxton et al., 2004) . However, common clinical tests of semantic memory, such as semantic fluency, may not be sensitive enough to specific kinds of disturbances in semantic object processing associated with PRC dysfunction that have been described in recent years (see e.g., Hirni et al., 2013; Kivisaari et al., 2012 Kivisaari et al., , 2013a Moss et al., 2005; Tyler et al., 2004) . More specific cognitive tasks based on cognitive neuroscience models of PRC functioning should be developed to take advantage of the progress made in this domain and translate it to the clinical research setting. Therefore, measures of cortical thickness can be applied most effectively as part of comprehensive multimodal diagnostic assessment for AD including advanced neuropsychological testing and where possible PET and/or MR functional imaging.
The present results demonstrate that the mPRC and ERC are atrophied in very early AD, whereas the thickness of the PHC remains within normal limits. The lPRC was significantly atrophied in the AD, but not in the aMCI group. Studies investigating more advanced AD patients demonstrate that all PHG substructuresdthe PRC, ERC, and PHCdare comparably atrophic. Thus, the present findings regarding mPRC and ERC thinning broadly map onto the hierarchical progression of neurofibrillary pathology described by Braak (1991, 1995) . Critically, they further suggest that cognitive impairments associated with the PHC (e.g., dysfunctional processing of visuospatial and landmark information) are still not present in the earliest stages of the AD, whereas those related to the mPRC and ERC represent promising cognitive markers of incipient AD.
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